Scientia Advisors in the News

---

Publications

---

Press Releases

---

Events

---

Luminary Insights

---

Media Contact

---

Scientia Advisors in the News

New Statesman quotes Harry Glorikian in "Pharma firms are increasingly seeking to outsource manufacturing"

New Statesman
June 4th, 2010

According to a review report released by Scientia Advisors, the move towards outsourcing pharmaceutical manufacturing to contract manufacturing organizations (CMOs) is part of an effort to keep costs down.

"With the market for biologic drugs growing much faster than that of drugs based on chemical compounds, pharmaceutical, biotechnology, generic drug and contract manufacturing companies are repositioning and forming new alliances in order to succeed in a rapidly changing landscape."

Read the full article here: New Statesman